Online Ahead Of Print

Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow

Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow

By

A review of HER2-positive breast cancer, including etiology, diagnosis, and treatments.

Challenges of Shared Decision Making in Prostate Cancer Screening

Challenges of Shared Decision Making in Prostate Cancer Screening

By

A review of shared decision making with men about undergoing PSA testing revealed that although full SDM discussions are increasing, variations in whether these discussions occur and how much information is shared still exist.

Venetoclax Found Effective in Relapsed/Refractory Chronic Lymphocytic Leukemia

Venetoclax Found Effective in Relapsed/Refractory Chronic Lymphocytic Leukemia

By

A group of Australian researchers report study findings that demonstrate a significant improvement in PFS in patients with relapsed/refractory CLL treated with venetoclax plus rituximab compared with the standard care.

Evidence-Based Practices, No CLABSIs Achieved Through Quality Improvement

Evidence-Based Practices, No CLABSIs Achieved Through Quality Improvement

By By

Faced with an increasing CLABSI rate on their oncology unit, nurse leaders at this rural Northwest hospital surveyed their staff to identify the changes they needed to make. Implementing those changes resulted in a dramatic improvement in patient care outcomes.

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

Cancer Screening Follow-up: Enabling Timely Diagnosis, Treatment

By

A review of the literature on follow-up after positive screening results led researchers to a consensus opinion on timing of diagnostic tests for 4 cancers: breast, cervical, colorectal, and lung.

Too Much Information: When Prognosis Breaks Down Patient Communications

Too Much Information: When Prognosis Breaks Down Patient Communications

By

Overwhelmed by her poor prognosis, a patient with a newly diagnosed advanced cancer cuts off communicating with her health care team.

Evolving Role of Radiation Therapy in the Treatment of Mesothelioma

Evolving Role of Radiation Therapy in the Treatment of Mesothelioma

By

Research into the potential of radiation therapy in the management of mesothelioma may improve the prognosis, and possibly extend progression-free survival, for patients with this incurable cancer.

Challenges for Young Adult Couples Facing a Cancer Diagnosis

Challenges for Young Adult Couples Facing a Cancer Diagnosis

A cancer diagnosis can alter life plans for a young adult couple, completely upending their carefully thought out plans. Understanding their unique challenges can ensure oncology nurses are prepared to help these patients and their partners face an uncertain future.

Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors

Testicular Cancer Treatment May Increase Risk for Heart Disease in Survivors

By

Recent research shows that although testicular cancer survivors do not totally conform to the criteria for metabolic syndrome, past treatment with platinum-based chemotherapy increases its prevalence among survivors and may lead to a greater risk for heart disease in this patient population.

Does Better Breast Imaging Lead to Improved Outcomes or Increased Overdiagnosis?

Does Better Breast Imaging Lead to Improved Outcomes or Increased Overdiagnosis?

By

Advances in breast imaging such as DBT offer better, clearer images of breast tissue that can identify even low-grade DCIS tumors. But will more sensitive imaging lead to improved outcomes or increased overtreatment?

Spousal, Partner Perception of Coping Affects Adjustments in Breast Cancer

Spousal, Partner Perception of Coping Affects Adjustments in Breast Cancer

By

Male spouse or partner perspectives on a female patient's ability to cope was found to have a positive effect on her ability to cope and adjust to her disease. Unfortunately, this effect remains rarely researched and poorly understood among patients with breast cancer in same sex relationships.

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer

By

In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.

Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family

Letter-Writing Project Communicates Care Wishes to Healthcare Team, Family

By

What matters most to me, who matters most to me, and what do I want in my last days? Letter-writing project is a tool for patients to communicate their wishes for their last days.

Medical Terms in Patient Education: Using the Confusing to Explain the Complicated

Medical Terms in Patient Education: Using the Confusing to Explain the Complicated

By

Medical terminology can be a foreign language — or confusing, at the least — for many patients. Ann Brady uses a patient encounter to illustrate the potential miscommunication inherent in using "medicalese" in patient communication.

A Witness to Letting Go: Nursing Care at the End of Life

A Witness to Letting Go: Nursing Care at the End of Life

By

A new oncology nurse reflects on the first time she provided comfort care for a patient at the end of life and her family.

Managing Chemo Brain in Pediatric Survivors of Childhood Cancer

Managing Chemo Brain in Pediatric Survivors of Childhood Cancer

By

Reintegration to the general environment, particularly to school, can be challenging for survivors of childhood cancers. This review discusses how adverse effects such as chemo brain may present extra challenges for these patients and what can be done to ease patients' anxiety.

Advances in Prevention, Treatment of RT-Associated Radiodermatitis Hold Promise

Advances in Prevention, Treatment of RT-Associated Radiodermatitis Hold Promise

By

This review of radiodermatitis, a common adverse effect of radiation therapy, discusses preventive and treatment options available that reduce and/or minimize symptoms of the condition.

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

By

At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.

Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies

Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies

By

A review of management approaches to Hodgkin lymphoma in Europe vs the United States/North America demonstrates that although some differences exist, worldwide studies that would enhance patient outcomes are feasible.

New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment

New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment

By

Publication of the JNC 8 introduces a lower threshold for initiating hypertension treatment during cancer therapy.

Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based

Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based

By

Researchers compared the association between diets high in plant-based omega-3 polyunsaturated fatty acids (PUFAs) vs those high in marine-based PUFAs and the risk for breast cancer.

Sitting With Silence in End-of-Life Cancer Care

Sitting With Silence in End-of-Life Cancer Care

By

Modern oncologic care entails actively pursuing treatment and cure; however, at the end of life, the ability to share silence may be the best treatment.

Lung Cancer Screening: Risk-Targeting Approach vs NLST Eligibility Criteria

Lung Cancer Screening: Risk-Targeting Approach vs NLST Eligibility Criteria

By

In a review of data from the NLST, researchers sought to determine if a risk-targeting approach would more efficiently select high-risk persons for lung cancer screening than the eligibility criteria defined by the NLST.

LISTEN Combats the Loneliness of Facing Cancer Diagnosis, Treatment

LISTEN Combats the Loneliness of Facing Cancer Diagnosis, Treatment

By

LISTEN, a novel program developed at WVU School of Medicine, is designed to tackle loneliness — a significant health concern for patients with cancer.

Patient Support Program Provides Diversions During Chemotherapy Infusions

Patient Support Program Provides Diversions During Chemotherapy Infusions

By

A kind gesture toward friends during their chemotherapy infusions developed into a support organization that helps patients pass the time during their treatment.

When There Are No Words: Interpreting Patients' and Families' Subtle Messages

When There Are No Words: Interpreting Patients' and Families' Subtle Messages

By

Although many physical expressions are universal, oncology nurses may be challenged to catch notice of more subtle body language from patients or a family member.

Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer

Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer

By

A cancer diagnosis is wrought with challenges for young adults. This article identifies the unique support needs for patients aged 20 to 39 years with cancer.

Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer

Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer

By

Study evaluates the incidence of post-traumatic stress disorder in patients with cancer from diagnosis through survivorship.

Nurses Must Be Experienced, Feel Competent When Providing End-of-Life Care

Nurses Must Be Experienced, Feel Competent When Providing End-of-Life Care

By

An analysis of select responses to a survey conducted by researchers from the College of Nursing at South Dakota State University identified oncology nurses' comfort level in handling end-of-life care and patient education.

Bridging the Gap in Genetic Cancer Research Data on Minority Populations

Bridging the Gap in Genetic Cancer Research Data on Minority Populations

By

Investigators sought to determine why so few biospecimens were available for research from minority populations of women with breast cancer.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs